Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 9 (September)

1. Clinical outcomes of laboratory-observed preschool behavioral disinhibition at five-year follow-up.
   Biol Psychiatry, 62(6): 565-72. [Abstract] [Full-text]
2. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway.
   Mol Psychiatry, 12(9): 815-25. [Abstract] [Full-text]
3. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder.
   Schizophr Res, 95(1): 174-8. [Abstract] [Full-text]
4. Understanding Associations Between Serious Mental Illness and HIV Among Patients in the VA Health System.
   Psychiatr Serv, 58(9): 1165-72. [Abstract] [Full-text]
5. Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states).
   Eur Psychiatry. [Abstract] [Full-text]
6. Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.
   J Neurochem, 102(6): 1918-27. [Abstract] [Full-text]
7. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
   Arch Gen Psychiatry, 64(9): 1032-9. [Abstract] [Full-text]
8. Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese.
   Arch Gen Psychiatry, 64(9): 1015-24. [Abstract] [Full-text]
9. The effect of gender on emotion perception in schizophrenia and bipolar disorder.
   Acta Psychiatr Scand, 116(4): 263-70. [Abstract] [Full-text]
10. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    J Child Adolesc Psychopharmacol, 17(4): 475-86. [Abstract] [Full-text]
11. Lack of RIC-3 congruence with beta2 subunit-containing nicotinic acetylcholine receptors in bipolar disorder.
    Neuroscience, 148(2): 454-60. [Abstract] [Full-text]
12. Bipolar disorder not otherwise specified: comparison with bipolar disorder I/II and major depression.
    Aust N Z J Psychiatry, 41(10): 843-9. [Abstract] [Full-text]
13. Sociodemographic, functional and clinical correlates in outpatients with schizophrenia: comparison with affective disorders.
    Aust N Z J Psychiatry, 41(10): 809-18. [Abstract] [Full-text]
14. Cotard's syndrome in adolescents and young adults is associated with an increased risk of bipolar disorder.
    Bipolar Disord, 9(6): 665-668. [Abstract] [Full-text]
15. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment.
    Bipolar Disord, 9(6): 656-64. [Abstract] [Full-text]
16. Post-traumatic stress disorder among adolescents with bipolar disorder and its relationship to suicidality.
    Bipolar Disord, 9(6): 649-55. [Abstract] [Full-text]
17. Is bipolar disorder overdiagnosed among patients with substance abuse?
    Bipolar Disord, 9(6): 646-8. [Abstract] [Full-text]
18. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study.
    Bipolar Disord, 9(6): 636-45. [Abstract] [Full-text]
19. Immune variations in bipolar disorder: phasic differences.
    Bipolar Disord, 9(6): 596-602. [Abstract] [Full-text]
20. Coping styles in prodromes of bipolar mania.
    Bipolar Disord, 9(6): 589-95. [Abstract] [Full-text]
21. Genome-wide scan of bipolar II disorder.
    Bipolar Disord, 9(6): 580-8. [Abstract] [Full-text]
22. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.
    Bipolar Disord, 9(6): 571-9. [Abstract] [Full-text]
23. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.
    Bipolar Disord, 9(6): 561-70. [Abstract] [Full-text]
24. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.
    Bipolar Disord, 9(6): 551-60. [Abstract] [Full-text]
25. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
    Mol Psychiatry. [Abstract] [Full-text]
26. Bipolar disorder: Balancing mood states early in course of illness effects long-term prognosis.
    Physiol Behav, 92(1): 199-202. [Abstract] [Full-text]
27. Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal.
    Hum Mol Genet, 16(19): 2288-305. [Abstract] [Full-text]
28. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
    Neuropsychopharmacology, 32(10): 2173-83. [Abstract] [Full-text]
29. Clinical and research implications of panic-bipolar comorbidity in children and adolescents.
    Psychiatry Res, 153(1): 47-54. [Abstract] [Full-text]
30. DNA damage in bipolar disorder.
    Psychiatry Res, 153(1): 27-32. [Abstract] [Full-text]
31. Manic symptoms and quality of life in bipolar disorder.
    Psychiatry Res, 153(1): 33-8. [Abstract] [Full-text]
32. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    J Clin Psychopharmacol, 27(5): 498-502. [Abstract] [Full-text]
33. Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation.
    J Clin Psychopharmacol, 27(5): 493-7. [Abstract] [Full-text]
34. Bipolar spectrum disorder: differential diagnosis and treatment.
    Prim Care, 34(3): 521-50. [Abstract] [Full-text]
35. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.
    Psychosomatics, 48(5): 412-7. [Abstract] [Full-text]
36. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
    Lipids Health Dis, 6(1): 21. [Abstract] [Full-text]
37. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
    J Psychopharmacol, 21(7): 768-73. [Abstract] [Full-text]
38. Burden, coping and needs for support of caregivers for patients with a bipolar disorder: a systematic review.
    J Psychiatr Ment Health Nurs, 14(7): 679-87. [Abstract] [Full-text]
39. Cortical neurochemistry in euthymic patients with bipolar I disorder.
    World J Biol Psychiatry. [Abstract] [Full-text]
40. Bipolar disorder preceded by substance abuse: A different phenotype with not so poor outcome?
    World J Biol Psychiatry. [Abstract] [Full-text]
41. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
    Neuroreport, 18(15): 1595-8. [Abstract] [Full-text]
42. A functional magnetic resonance imaging study of emotional Stroop in euthymic bipolar disorder.
    Neuroreport, 18(15): 1583-7. [Abstract] [Full-text]
43. Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder.
    Neuroreport, 18(15): 1567-70. [Abstract] [Full-text]
44. Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents.
    J Am Acad Child Adolesc Psychiatry, 46(10): 1299-306. [Abstract] [Full-text]
45. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Ann Pharmacother, 41(10): 1593-603. [Abstract] [Full-text]
46. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study.
    Heart, 93(10): 1256-62. [Abstract] [Full-text]
47. Current issues in bipolar disorder: a critical review.
    Eur Neuropsychopharmacol, 17(11): 687-95. [Abstract] [Full-text]
48. Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
    J Psychiatr Pract, 13(5): 291-7. [Abstract] [Full-text]
49. Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes.
    Clin Pract Epidemol Ment Health, 3(1): 17. [Abstract] [Full-text]
50. HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo.
    Genet Vaccines Ther, 5(1): 10. [Abstract] [Full-text]
51. Clinical trials: bridging the gap between efficacy and effectiveness.
    Int Rev Psychiatry, 19(5): 531-9. [Abstract] [Full-text]
52. Case identification in psychiatric epidemiology: a review.
    Int Rev Psychiatry, 19(5): 497-507. [Abstract] [Full-text]
53. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial.
    JAMA, 298(12): 1401-11. [Abstract] [Full-text]
54. Temporal lobe and "default" hemodynamic brain modes discriminate between schizophrenia and bipolar disorder.
    Hum Brain Mapp. [Abstract] [Full-text]
55. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Am J Psychiatry, 164(10): 1547-56. [Abstract] [Full-text]
56. White matter hyperintensities and their associations with suicidality in patients with major affective disorders.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
57. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders.
    Neurosci Lett, 426(1): 49-53. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.